$2.440
+0.242 (+9.91%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
ATHE Prediction & Forecast by Similar Chart Analysis
Alphio's ATHE stock price prediction model matches the current Alterity Therapeutics Limited tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.47 (+1.16%). The 1-week path is $2.45 (+0.25%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Alterity Therapeutics Limited Stock?
Alterity Therapeutics is not a strong buy right now due to its current price of $2.09, which is significantly below the analyst price targets of $10 to $16. The RSI is at 24, indicating oversold conditions, but the stock has a high risk with a 20-day change of -35.09%, suggesting recent volatility. While positive FDA feedback for ATH434 is promising, the stock's performance reflects market skepticism and a lack of momentum.
ATHE stock price ended at $2.44 on Friday, after rising +9.91%
Alterity Therapeutics Limited (ATHE) last closed at $2.4400001, gaining +9.91%. These facts feed the 1-day and 1-week ATHE price prediction above.
Forecast Drivers
Alterity Therapeutics Limited (ATHE) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bearish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches ATHE, ranked by similarity.
Seasonality analysis for ATHE
Historically the probability of a positive November return for ATHE is 15.91%. June offers the highest probability of a positive month at 68.33%, while December is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for ATHE
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Nov 2026 | $4.99 | $5.39 | $6.43 | +120.79% |
| Dec 2026 | $4.13 | $4.94 | $5.55 | +102.61% |
In 2026, Alterity Therapeutics Limited (ATHE) is projected to range from $4.13 to $6.43.
Alterity Therapeutics Limited 2026 monthly forecast
In Nov 2026, Alterity Therapeutics Limited is projected to average $5.39, with a low of $4.99 and high of $6.43.
In Dec 2026, Alterity Therapeutics Limited is projected to average $4.94, with a low of $4.13 and high of $5.55.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.